These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HBsAg prevalence in blood donors in Jaipur. Nijhawan S; Rai RR; Sharma D; Saxena HB Indian J Gastroenterol; 1997 Oct; 16(4):162. PubMed ID: 9357200 [No Abstract] [Full Text] [Related]
4. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Singh B; Verma M; Verma K Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208 [TBL] [Abstract][Full Text] [Related]
5. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Larsen J; Hetland G; Skaug K Transfusion; 1990 Jun; 30(5):431-2. PubMed ID: 2360234 [TBL] [Abstract][Full Text] [Related]
7. Current status of post-transfusion hepatitis. Conrad ME Am J Hematol; 1976; 1(3):357-65. PubMed ID: 63244 [No Abstract] [Full Text] [Related]
8. [Progress in research of occult hepatitis B virus infection]. Huang XY; Shi QF; Huang T Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):688-692. PubMed ID: 28651413 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Ejele OA; Ojule AC Niger J Med; 2004; 13(4):336-8. PubMed ID: 15523857 [TBL] [Abstract][Full Text] [Related]
11. Comments on the role of epidemiology in the investigation of hepatitis B virus. London WT; Blumberg BS Epidemiol Rev; 1985; 7():59-79. PubMed ID: 2996918 [No Abstract] [Full Text] [Related]
13. [Post-transfusion hepatitis. Effects of long-term screening for HBsAg carriers among blood donors]. Pintera J Cas Lek Cesk; 1982 Sep; 121(37):1148-52. PubMed ID: 7139671 [No Abstract] [Full Text] [Related]
14. Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients? Gérard C; Vaira D; Delwaide J; Lamproye A; Maggipinto G; Sondag D; Rorive G; Belaïche J; Rentier B Vox Sang; 1998; 75(1):77. PubMed ID: 9779566 [No Abstract] [Full Text] [Related]
15. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Alter HJ; Holland PV; Purcell RH; Lander JJ; Feinstone SM; Morrow AG; Schmidt PJ Ann Intern Med; 1972 Nov; 77(5):691-9. PubMed ID: 4628213 [No Abstract] [Full Text] [Related]
16. The emerging pattern of post-transfusion hepatitis. Alter HJ; Holland PV; Purcell RH Am J Med Sci; 1975; 270(2):329-34. PubMed ID: 1235474 [TBL] [Abstract][Full Text] [Related]
17. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Aach RD; Alter HJ; Hollinger FB; Holland PV; Lander JJ; Melnick JL; Weiler JM Lancet; 1974 Jul; 2(7874):190-3. PubMed ID: 4135609 [No Abstract] [Full Text] [Related]
18. Trends in hepatitis B virus infection among blood donors in Kelantan, Malaysia: a retrospective study. Yousuf R; Rapiaah M; Ahmed SA; Rosline H; Salam A; Selamah S; Roshan TM Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1070-4. PubMed ID: 18613548 [TBL] [Abstract][Full Text] [Related]
19. Distribution of subtypes of hepatitis B surface antigen in Western India. Joshi SH; Bapat JP; Bhatia HM; Baxi AJ Vox Sang; 1979; 36(4):199-200. PubMed ID: 462908 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of hepatitis B surface antigen in the Gezira (Sudan). Elshafie SS Afr J Med Med Sci; 1992 Oct; 21(1):61-3. PubMed ID: 1288244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]